Development and Implementation of Ramadan Fasting Algorithm for Singaporeans With Type 2 Diabetes

Diabetes Mellitus, Type 2 Clinical Trial

— FAST  

Official title:

Development and Implementation of Ramadan "Fasting Algorithm for Singaporeans With Type 2 Diabetes" (FAST): A Prospective Randomized Controlled Intervention Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03314246
• Other study ID #: 2016/00290
• Status: Completed
• Phase: N/A
• Start date: April 3, 2017
• Est. completion date: February 6, 2019

Study information

• Verified date: February 2020
• Source: National University, Singapore
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Background: Ramadan fasting is a religious observance carried out by Muslims all over the world. During Ramadan, Muslims abstain from eating, drinking, and smoking during daylight hours. Although Muslims who are ill, including patients with diabetes, are exempted from fasting, many devoted Muslim patients still insist on fasting despite being advised not to by their healthcare providers. Concerns have been raised over how the practice of fasting may affect the metabolic control of Muslim patients with diabetes. Furthermore, it has also been postulated that the act of fasting may increase the risk of hypoglycemia or glucose toxicity. Although practice algorithms and suggestions on the use of glycemic therapies during fasting have been discussed internationally. they are not generalizable as the observances of Ramadan, duration of fasting and the food ingested differ from one country to another.

Aims: This study aims to develop and implement a clinical practice dose-adjustment algorithm dedicated to the care of Singaporean patients with diabetes who fast during Ramadan.

Hypothesis: The use of clinical practice dose-adjustment algorithm can improve both clinical and humanistic outcomes of patients with type 2 diabetes who wish to fast during Ramadan.

Methods: This is a prospective, randomized, interventional study involving patients with type 2 diabetes who wish to fast for at least 10 days during Ramadan. Eligible patient attending a primary care institution or an outpatient specialist clinic of a tertiary institution will be approached to participate in the study. Consented patients will be randomized to either intervention arm or control arm. Patients in the control arm will receive usual care while patients in the intervention arm will be given additional education session on Ramadan fasting related diabetic management advice and an algorithm that was developed by the study team members based on international guidelines, to guide them on self-management during Ramadan. The primary outcomes will be change in HbA1c. Secondary outcomes include change in fasting blood glucose, post prandial blood glucose, medication adherence and humanistic outcomes. The safety outcomes include self reported incidence of major and minor hypoglycemia as well as hyperglycemia during Ramadan month. All outcomes will be measured at baseline, during Ramadan and at 3 month post Ramadan.

Significance: The validation of the algorithm through this study will ensure effective and safe fasting of patients with type 2 diabetes during Ramadan.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 111
• Est. completion date: February 6, 2019
• Est. primary completion date: February 6, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 21 Years to 90 Years

Eligibility

Inclusion Criteria:

• All Muslim patients over 21 years of age with Type 2 diabetes who plan to fast for at least 10 days during the month of Ramadan

Exclusion Criteria:

• Patients with history of recurrent hypoglycemia

• Patients who are pregnant

• Patients with eGFR<30ml/min 3 months prior to Ramadan

• Patients with HbA1c > 9.5%

• Patients with DM-related admission 1 month prior to Ramadan

• Patients on active short-term corticosteroid treatment

• Patients who are unable to complete the questionnaires

Related Conditions & MeSH terms

• Diabetes Mellitus
• Diabetes Mellitus, Type 2

Intervention

Other:
• FAST
Fasting Algorithm for Singaporeans with Type 2 Diabetes
• Standard of care
Standard of care

Locations

Country	Name	City	State
Singapore	National Healthcare Group Polyclinic (Bukit Batok)	Singapore
Singapore	Tan Tock Seng Hospital	Singapore

Sponsors (4)

Lead Sponsor	Collaborator
Joyce Lee	National Healthcare Group, Singapore, National University, Singapore, Tan Tock Seng Hospital

Country where clinical trial is conducted

Singapore, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in HbA1c	Change in HbA1c during and after Ramadan from baseline	Baseline Pre-Ramadan (3 months prior to Ramadan), during Ramadan (+ 4 weeks) and post Ramadan (3 months after Ramadan)
Secondary	Incidence of minor and major hypoglycemia	Incidence of minor hypoglycemia which is defined as signs and symptoms with known precipitating causes such as irregular eating habits, increased daily activity or other attributes that can be modified. Major hypoglycemia is defined as any hypoglycemic symptoms that require the help from another person.	During one month of Ramadan
Secondary	Incidence of hyperglycemia	Incidence of hyperglycemia which is defined as signs and symptoms of frequent urination, increased thirst or fruity-smelling breath.	During one month of Ramadan
Secondary	Change in fasting blood glucose (FPG)	Change in FPG during and after Ramadan from baseline	Baseline Pre-Ramadan (3 months prior to Ramadan), during Ramadan (+ 4 weeks) and post Ramadan (3 months after Ramadan)
Secondary	Change in post-prandial blood glucose	Change in 2 hours post meal during and after Ramadan from baseline	Baseline Pre-Ramadan (3 months prior to Ramadan), during Ramadan (+ 4 weeks) and post Ramadan (3 months after Ramadan)
Secondary	Change in blood pressure	Change in BP during and after Ramadan from baseline	Baseline Pre-Ramadan (3 months prior to Ramadan), during Ramadan (+ 4 weeks) and post Ramadan (3 months after Ramadan)
Secondary	Change in lipid panel	including LDL, TG, TC, HDL	Baseline Pre-Ramadan (3 months prior to Ramadan) and post Ramadan (3 months after Ramadan)
Secondary	Change in general health status	EQ-5D-5L	Baseline Pre-Ramadan (3 months prior to Ramadan) and during Ramadan (+ 4 weeks)
Secondary	Change in diabetes-related distress	Problem Area in Diabetes (PAID)	Baseline Pre-Ramadan (3 months prior to Ramadan) and during Ramadan (+ 4 weeks)
Secondary	Change in diabetes-specific quality of life	Audit of Diabetes Dependent Quality of Life (ADDQoL)	Baseline Pre-Ramadan (3 months prior to Ramadan) and during Ramadan (+ 4 weeks)
Secondary	Change in diabetes treatment satisfaction	Diabetes Treatment Satisfaction Questionnaires (DTSQ)	Baseline Pre-Ramadan (3 months prior to Ramadan) and during Ramadan (+ 4 weeks)